Form 4: Singular Genomics CFO Dalen Meeter Reports Stock Transactions

Dalen Meeter, CFO of Singular Genomics Systems, Inc., reports the acquisition and disposal of company stock and restricted stock units.

Summary

• On February 9, 2025, Dalen Meeter, the Chief Financial Officer of Singular Genomics Systems, Inc. (OMIC), engaged in transactions involving the company's stock.
• Meeter acquired 500 shares of Common Stock upon the vesting of Restricted Stock Units (RSUs).
• Meeter also disposed of 500 shares of Common Stock.
• Following these transactions, Meeter directly owns 9,502 shares of Common Stock.
• Meeter also holds 6,000 Restricted Stock Units (RSUs).

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, like the CFO, and provides transparency into their trading activities in the company's stock. It's a standard practice for publicly traded companies.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider transactions.
• It helps maintain investor confidence by ensuring compliance with securities regulations.

Key Dates

Keywords

Singular Genomics, OMIC, Form 4, Dalen Meeter, CFO, Stock, Restricted Stock Units, RSU, Beneficial Ownership, Securities